EFFECT OF NORFLOXACIN ON THEOPHYLLINE PHARMACOKINETICS AT STEADY-STATE

被引：40
|
作者：
BOWLES, SK
POPOVSKI, Z
RYBAK, MJ
BECKMAN, HB
EDWARDS, DJ
机构：
[1] WAYNE STATE UNIV,COLL PHARM & ALLIED HLTH PROFESS,DETROIT,MI 48202
[2] WAYNE STATE UNIV,SCH MED,DETROIT,MI 48202
[3] DETROIT RECEIVING HOSP,UNIV HLTH CTR,DEPT PHARM SERV,DETROIT,MI 48201
[4] DETROIT RECEIVING HOSP UNIV HLTH CTR,DEPT MED,DETROIT,MI 48201
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1988年 / 32卷 / 04期
关键词：
D O I：
10.1128/AAC.32.4.510
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：510 / 512
页数：3
相关论文
共 50 条
  • [41] The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans
    Niopas, I
    Toon, S
    Aarons, L
    Rowland, M
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (05) : 399 - 404
  • [42] PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN AT STEADY-STATE
    ROUTLEDGE, PA
    CHAPMAN, PH
    DAVIES, DM
    RAWLINS, MD
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (03) : 243 - 247
  • [43] STEADY-STATE PHARMACOKINETICS OF MIDAZOLAM MALEATE
    SARNQUIST, FH
    GUSTAFSON, J
    BLASCHKE, T
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (02) : 283 - 284
  • [44] Effect of steady-state faldaprevir on the pharmacokinetics of steady-state methadone and buprenorphine/naloxone in subjects on stable addiction management therapy
    Joseph, David
    Schobelock, Michael J.
    Riesenberg, Robert A.
    Vince, Bradley
    Webster, Lynn R.
    Adeniji, Abidemi
    Elgadi, Mabrouk
    Huang, Fenglei
    HEPATOLOGY, 2013, 58 : 440A - 441A
  • [45] CIRCADIAN VARIATION IN STEADY-STATE TROUGH THEOPHYLLINE CONCENTRATIONS
    REED, RC
    SCHWARTZ, HJ
    THERAPEUTIC DRUG MONITORING, 1986, 8 (02) : 155 - 160
  • [46] MOGUISTEINE, A NEW ANTITUSSIVE DRUG, HAS NO EFFECT ON STEADY-STATE THEOPHYLLINE PHARMACOKINETICS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    GUFFANTI, EE
    SCARPAZZA, P
    COLOMBO, D
    CANALI, S
    RATTI, D
    SCARPAZZA, G
    MARCHI, E
    ADVANCES IN THERAPY, 1995, 12 (03) : 185 - 197
  • [47] CHRONOPHARMACOKINETICS IN STEADY-STATE OF A SUSTAINED-RELEASE THEOPHYLLINE
    SEGRESTAA, JM
    DAHAN, R
    HOULBERT, D
    CAULIN, C
    RONNEL, A
    ABELLA, ML
    THERAPIE, 1984, 39 (06): : 633 - 637
  • [48] STEADY-STATE PHARMACOKINETICS OF 2 DIFFERENT SUSTAINED-RELEASE THEOPHYLLINE PREPARATIONS IN HEALTHY-VOLUNTEERS
    KELLER, A
    SCHULZ, HU
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1994, 44-2 (11): : 1233 - 1236
  • [49] PHARMACOKINETICS OF A NEW LONG-ACTING LIQUID THEOPHYLLINE PRODUCT .2. STEADY-STATE EVALUATION
    HARRISON, LI
    DEVANE, JG
    BOTTINI, PB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (02) : 152 - 152
  • [50] THE EFFECT OF FLUCONAZOLE ON THE STEADY-STATE PHARMACOKINETICS AND ELECTROCARDIOGRAPHIC PHARMACODYNAMICS OF TERFENADINE IN HUMANS
    HONIG, PK
    WORTHAM, DC
    ZAMANI, K
    MULLIN, JC
    CONNER, DP
    CANTILENA, LR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (06) : 630 - 636
12345